Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Caseshaematology-oncology-and-transfusion

Paeds Cases · haematology-oncology-and-transfusion

Sickle cell disease: diagnosis and health maintenance: Case

Clinical case of a boy with sickle cell anaemia diagnosed on newborn screening, covering the FS pattern on high-performance liquid chromatography, the penicillin prophylaxis schedule with exact doses, the encapsulated-organ immunisation, the hydroxyurea decision from nine months, the annual transcranial Doppler with chronic transfusion for the abnormal result, and the family counselling and the multidisciplinary plan.

paediatric haematology long case4 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A six-year-old boy with known HbSS sickle cell disease, diagnosed on newborn screening, attends the sickle cell clinic for his annual review. He is on penicillin V 250 mg twice daily, hydroxyurea 28 mg per kg per day, and the full immunisation schedule. His most recent transcranial Doppler shows a time-averaged mean velocity of 205 cm per second in the right middle cerebral artery, up from 175 cm per second last year. His full blood count shows a haemoglobin of 78 g per litre, a reticulocyte count of 12 percent, and a fetal haemoglobin of 18 percent. The examiner asks how you interpret the Doppler, what you do now, and how you counsel the family.

This boy has HbSS sickle cell disease, well managed on penicillin, hydroxyurea, and full immunisation, and the new finding is the abnormal transcranial Doppler. The right middle cerebral artery time-averaged mean velocity of 205 cm per second crosses the 200 cm per second threshold that defines the abnormal result, and this is a pre-stroke state that demands action. The annual trend, up from 175 cm per second last year, confirms that this is a new and real change rather than a measurement artefact. [3]

Interpretation of the findings

The key findings are the abnormal transcranial Doppler, the steady-state chronic haemolysis, and the good hydroxyurea response. The time-averaged mean velocity of 205 cm per second is abnormal, because the threshold is 200 cm per second or more, and the STOP trial showed that such a child has a high risk of a first stroke without treatment. The haemoglobin of 78 g per litre and the reticulocyte count of 12 percent are the expected steady state of HbSS, the chronic haemolysis, and the fetal haemoglobin of 18 percent shows a good response to the hydroxyurea, which is why his disease has been well controlled to this point. [8]

The penicillin and the immunisation are appropriately maintained, and there is no sign yet of organ injury. The question is not whether he is sick today, because he is not, but whether the abnormal Doppler is allowed to progress to a stroke, which it will in a substantial minority of untreated children. The interpretation is therefore that the boy has moved from a screened, low-risk child to one who needs a chronic transfusion programme to prevent a stroke. [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [3]Adams RJ, McKie VC, Hsu L Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med, 1998.PMID 9647873
  2. [5]Yawn BP, Buchanan GR, Afenyi-Annan AN Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA, 2014.PMID 25203083
  3. [7]Ware RE, Davis BR, Schultz WH Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet, 2016.PMID 26670617
  4. [8]DeBaun MR, Jordan LC, King AA American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv, 2020.PMID 32298430
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSickle cell acute complications: Casehaematology-oncology-and-transfusionNextThalassaemia syndromes: Casehaematology-oncology-and-transfusion